CELL & GENE ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS

• Mycoplasma Testing In Monoclonal Antibody Production

  Prevent costly disruptions in your bioproduction process. Discover how a PCR-based method can quickly detect the presence of mycoplasmas in raw materials, cell banks, and in-process and lot-release samples.

• Simpler, Faster, Cheaper Advanced Therapy Manufacturing

  Discover how TFDF-based perfusion technology boosts lentiviral vector production by over 10-fold, slashes costs, and accelerates the commercialization of CAR-T and other advanced cell therapies.

• The Hidden Costs Of Paper Logbooks

  Stop losing time and capacity to manual paperwork. Learn how digital workflows eliminate compliance risks and unlock the actionable data needed to optimize life sciences manufacturing.

• Optimizing DPI Production: Filling Technologies For Precision And Performance

  Developing effective dry powder inhalers requires expertise across multiple disciplines, from particle engineering and device technology to manufacturing science and regulatory knowledge.

• Challenges And Solution In The Poly (A) Control For Plasmid And mRNA

  Poly(A) tail integrity is critical for mRNA stability and translation. Advanced strategies optimize plasmid design, transcription, and purification to ensure consistent poly(A) control for therapeutic success.

• Select The Best Analyte: A Guide To Effective Mycoplasma Testing

  As you build a Mycoplasma testing strategy to ensure drug safety, there are three analyte types to choose from: live Mycoplasma, RNA, and genomic DNA, each offering distinct advantages.

• A Better Immune Response To Vaccination: Using Lymphoid Follicle Organ-Chips

  Discover a first-of-its-kind human LF-Chip containing B, T, plasma and antigen-presenting cells to test functional immunization responses to vaccines and adjuvants in vitro.

• Optimizing Performance For De-Risked Lentiviral Vector Production

  Discover a de-risked, reproducible, and scalable platform for efficient GMP manufacturing of lentiviral vectors that maximizes titers and enriches recovery through upstream and downstream optimization.

• Understanding EndoCleave's Role In Viral Vector Manufacturing

  Achieving high-quality viral vectors demands rigorous control over contaminants. Learn about enzymatic approaches to significantly reduce nucleic acid impurities in your manufacturing processes.

• Contamination In The Shadows: Risks Lurking From Environmental Issues

  Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.